ArticleCancer management and research2026

Prognostic Impact of the Systemic Immune-Inflammation Index in Unresectable Hepatocellular Carcinoma Undergoing Second-Line Combination Therapy: A Multicenter Study.

Xiaoshuang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.